Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics

Clinica Chimica Acta

Volumn 339, Issue 1-2, 2004, Pages 1-9

  Wu, Lily L ^a   Chiou, Chiuan Chian ^b   Chang, Pi Yueh ^c   Wu, James T ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Atherosclerosis; Cancer; Diabetes; ELISA; Oxidative stress; Risk factor; Urinary 8 OhdG

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CELL NUCLEUS DNA; CREATININE; DNA; LIPID; M PROTEIN; MITOCHONDRIAL DNA; NUCLEIC ACID; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BREAST CANCER; CANCER; CANCER RISK; CARCINOGENESIS; CORONARY RISK; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DNA DAMAGE; DNA DENATURATION; DNA REPAIR; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; LIPID DEGRADATION; NOMENCLATURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; RISK FACTOR; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION;

EID: 0345735389     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.09.010     Document Type: Review

References (54)

1. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 3rd ed. 1999;Oxford Univ. Press, Oxford. OX2 6DP.
2. Loft S., Vistisen K., Ewertz M., Tjonneland A., Overvad K., Poulsen H.E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 13:1992;2241-2247.
3. Cooke M.S., Evans M.D., Burd R.M., Patel K., Barnard A., Lunec J.et al. Induction and excretion of ultraviolet-induced 8-oxo-2′-deoxyguanosine and thymine dimers in vivo: implications for PUVA. J. Invest. Dermatol. 116:2001;281-285.
4. Chiou C-C, Chang P-Y, Chan E-C, Wu T-L, Tsao K-C, Wu TJ, Urinary 8-hydroxydeoxyguanosine and its analogues as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin. Chim. Acta [in press].
5. Cooke M.S., Lunec J., Evans M.D. Progress in the analysis of urinary oxidative DNA damage. Free Radic. Biol. Med. 33:2002;1601-1614.
6. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 387:1997;147-163.
7. Marczynski B., Kraus T., Rozynek P., Raithel H.J., Baur X. Association between 8-hydroxy-2′-deoxyguanosine levels in DNA of workers highly exposed to asbestos and their clinical data, occupational and non-occupational confounding factors, and cancer. Mutat. Res. 10(468):2000;203-212.
8. Cooke M.S., Patel K., Ahmad J., Holloway K., Evans M.D., Lunec J. Monoclonal antibody to single-stranded DNA: a potential tool for DNA repair studies. Biochem. Biophys. Res. Commun. 284:2001;232-238.
9. Weimann A., Belling D., Poulsen H.E. Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry. Nucleic Acids Res. 30:2002;E7.
10. Cooke M.S., Evans M.D., Herbert K.E., Lunec J. Urinary 8-oxo-2′-deoxyguanosine-source, significance and supplements. Free Radic. Res. 32:2000;381-397.
11. Loft S., Poulsen H.E. Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim. Pol. 45:1998;133-144.
12. Janssen K., Schlink K., Gotte W., Hippler B., Kaina B., Oesch F. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat. Res. 486:2001;207-216.
13. Germadnik D., Pilger A., Rudiger H.W. Assay for the determination of urinary 8-hydroxy-2′-deoxyguanosine by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B. Biomed. Sci. Appl. 689:1997;399-403.
14. Lengger C., Schoch G., Topp H. A high-performance liquid chromatographic method for the determination of 8-oxo-7,8-dihydro-2′-deoxyguanosine in urine from man and rat. Anal. Biochem. 287:2000;65-72.
15. Tsuboi H., Kouda K., Takeuchi H., Takigawa M., Masamoto Y., Takeuchi M. et al. 8-hydroxydeoxyguanosine in urine as an index of oxidative damage to DNA in the evaluation of atopic dermatitis. Br. J. Dermatol. 138:1998;1033-1035.
16. Shimoi K., Kasai H., Yokota N., Toyokuni S., Kinae N. Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2′-deoxyguanosine in human urine. Cancer Epidemiol. Biomarkers Prev. 11:2002;767-770.
17. Klungland A., Rosewell I., Hollenbach S., Larsen E., Daly G., Epe B.et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13300-13305.
18. DeWeese T.L., Shipman J.M., Larrier N.A., Buckley N.M., Kidd L.R., Groopman J.D.et al. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11915-11920.
19. Mazurek A., Berardini M., Fishel R. Activation of human mutS homologs by 8-oxo-guanine DNA damage. J. Biol. Chem. 277:2002;8260-8266.
20. Poulsen H.E., Prieme H., Loft S. Role of oxidative DNA damage in cancer initiation and promotion. Eur. J. Cancer Prev. 7:1998;9-16.
21. Halliwell B. Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic. Biol. Med. 32(1,2):2002;968-974.
22. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 358:1995;1-3.
23. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:1991;794-798.
24. Foksinski M., Kotzbach R., Szymanski W., Olinski R. The level of typical biomarker of oxidative stress 8-hydroxy-2′-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor. Free Radic. Biol. Med. 29:2000;597-601.
25. Matsui A., Ikeda T., Enomoto K.et al. Increased formation of oxidative DNA damage, 8-hydroxy-2′deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 ad COMT genotypes. Cancer Lett. 151:2000;87-95.
26. Djuric Z., Heibrun L.K., Simon M.S.et al. Levels of 5-hydroxymethyl- 2′-deoxyuridine in DNA from blood as a marker of breast cancer. Cancer. 77:1996;691-696.
27. Erhola M., Toyokuni S., Okada K.et al. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′- deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett. 409:1997;287-291.
28. Kitada T., Seki S., Iwai S., Yamada T., Sakaguchi H., Wakasa K. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J. Hepatol. 35:2001;613-618.
29. Kato J., Kobune M., Nakamura T., Kuroiwa G., Takada K., Takimoto R. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res. 61:2001;8697-8702.
30. Musarrat J., Arezina-Wilson J., Wani A.A. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur. J. Cancer. 32A:1996;1209-1214.
31. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Brasen J.H., Skatchkov M.et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 99:1999;2027-2033.
32. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 43:1999;562-571.
33. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 106:2002;927-932.
34. Burney S., Niles J.C., Dedon P.C., Tannenbaum S.R. DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitrite. Chem. Res. Toxicol. 12:1999;513-520.
35. Maritim A.C., Sanders R.A., Watkins J.B. III Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17:2003;24-38.
36. Kanauchi M., Nishioka H., Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron. 91:2002;327-329.
37. Negishi H., Ikeda K., Kuga S., Noguchi T., Kanda T., Njelekela M.et al. The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J. Hypertens. 19:2001;529-533.
38. Dincer Y., Akcay T., Alademir Z., Ilkova H. Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat. Res. 505:2002;75-81.
39. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care. 5:2002;561-568.
40. Hinokio Y., Suzuki S., Hirai M., Suzuki C., Suzuki M., Toyota T. Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia. 45:2002;877-882.
41. Kanauchi M., Nishioka H., Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron. 91:2002;327-329.
42. Augustin A.J., Dick H.B., Koch F., Schmidt-Erfurth U. Correlation of blood-glucose control with oxidative metabolites in plasma and vitreous body of diabetic patients. Eur. J. Ophthalmol. 12:2002;94-101.
43. Shin C.S., Moon B.S., Park K.S., Kim S.Y., Park S.J., Chung M.H.et al. Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 24:2001;733-737.
44. Hamilton M.L., Van Remmen H., Drake J.A., Yang H., Guo Z.M., Kewitt K.et al. Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. U. S. A. 98:2001;10469-10474.
45. Kinoshita A., Wanibuchi H., Imaoka S., Ogawa M., Masuda C., Morimura K. et al. Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21(WAF1/Cip1), cyclin D1 and Ogg1. Carcinogenesis. 23:2002;341-349.
46. Howard D.J., Ota R.B., Briggs L.A., Hampton M., Pritsos C.A. Environmental tobacco smoke in the workplace induces oxidative stress in employees, including increased production of 8-hydroxy-2′-deoxyguanosine. Cancer Epidemiol. Biomarkers Prev. 7:1998;141-146.
47. Loft S., Fischer-Nielsen A., Jeding I.B., Vistisen K., Poulsen H.E. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health. 40(2-3):1993 (Oct.-Nov.);391-404.
48. Pilger A., Germadnik D., Riedel K., Meger-Kossien I., Scherer G., Rudiger H.W. Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults. Free Radic. Res. 35:2001;273-280.
49. Pourcelot S., Faure H., Firoozi F., Ducros V., Tripier M., Hee J.et al. Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5-(hydroxymethyl) uracil in smokers. Free Radic. Res. 30:1999;173-180.
50. Prieme H., Loft S., Nyyssonen K., Salonen J.T., Poulsen H.E. No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion in smokers. Am. J. Clin. Nutr. 65:1997;503-507.
51. Pilger A., Germadnik D., Riedel K., Meger-Kossien I., Scherer G., Rudiger H.W. Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults. Free Radic. Res. 35:2001;273-280.
52. Loft S., Poulsen H.E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 75:1996;67-68.
53. Cooke M.S., Evans M.D., Podmore I.D., Herbert K.E., Mistry N., Mistry P.et al. Novel repair action of vitamin C upon in vivo oxidative DNA damage. FEBS Lett. 439:1998;363-367.
54. Halliwell B. Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic. Res. 29:1998;469-486.